Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai University Affiliated Mengchao Cancer Hospital is a specialized oncology facility located in the Jiading District of Shanghai, China. Named after the pioneering hepatobiliary surgeon Wu Mengchao, the hospital operates under a unique clinical-research-industry integrated model in close partnership with the Shanghai Cell Therapy Group. It focuses on precision medicine and advanced immunotherapies, particularly CAR-T cell therapies, for the treatment of refractory solid tumors such as liver and pancreatic cancer. The hospital serves as a major clinical trial site for innovative cell-based products and is equipped with state-of-the-art diagnostic and therapeutic infrastructure to provide personalized cancer care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai University Affiliated Mengchao Cancer Hospital.